 | A1I67 | Name: | (2~{R},3~{S},6~{R},7~{S})-7-[(1~{S})-1-azanyl-3-methyl-butyl]-2,6-dimethyl-6,7-bis(oxidanyl)-1,4-oxazepane-3-carbaldehyde | Formula: | C13 H26 N2 O5 | SMILES: | CC(C)C[CH](N)[C]1(O)O[CH](C)[CH](NC[C]1(C)O)C(O)=O | InChi: | InChI=1S/C13H26N2O5/c1-7(2)5-9(14)13(19)12(4,18)6-15-10(11(16)17)8(3)20-13/h7-10,15,18-19H,5-6,14H2,1-4H3,(H,16,17)/t8-,9+,10+,12-,13+/m1/s1 | Definition date: | 2025-03-20 | Last modified: | 2025-04-03 | Release date: | 2025-04-02 | Identifier: | (2~{R},3~{S},6~{R},7~{S})-7-[(1~{S})-1-azanyl-3-methyl-butyl]-2,6-dimethyl-6,7-bis(oxidanyl)-1,4-oxazepane-3-carboxylic acid |
|
 | DCY | Name: | D-CYSTEINE | Formula: | C3 H7 N O2 S | SMILES: | O=C(O)C(N)CS | InChi: | InChI=1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2025-04-03 | Identifier: | D-cysteine |
|
 | A1BZQ | Name: | N-[(1R)-1-(2,4-dimethyl-1,3-thiazol-5-yl)ethyl]-2-methylpropanamide | Formula: | C11 H18 N2 O S | SMILES: | Cc1nc(C)sc1C(C)NC(=O)C(C)C | InChi: | InChI=1S/C11H18N2OS/c1-6(2)11(14)13-8(4)10-7(3)12-9(5)15-10/h6,8H,1-5H3,(H,13,14) | Definition date: | 2025-03-11 | Last modified: | 2025-03-28 | Release date: | 2025-04-02 | Identifier: | N-[(1R)-1-(2,4-dimethyl-1,3-thiazol-5-yl)ethyl]-2-methylpropanamide |
|
 | A1I4H | Name: | 9-[(3~{R},4~{R})-1-(3-azanylpropanoyl)-4-oxidanyl-pyrrolidin-3-yl]-1,3-dimethyl-purine-2,6-dione | Formula: | C14 H20 N6 O4 | SMILES: | CN1C(=O)N(C)c2n(cnc2C1=O)[CH]3CN(C[CH]3O)C(=O)CCN | InChi: | InChI=1S/C14H20N6O4/c1-17-12-11(13(23)18(2)14(17)24)16-7-20(12)8-5-19(6-9(8)21)10(22)3-4-15/h7-9,21H,3-6,15H2,1-2H3/t8-,9-/m1/s1 | Definition date: | 2025-02-24 | Last modified: | 2025-03-28 | Release date: | 2025-04-02 | Identifier: | 9-[(3~{R},4~{R})-1-(3-azanylpropanoyl)-4-oxidanyl-pyrrolidin-3-yl]-1,3-dimethyl-purine-2,6-dione |
|
 | A1B4O | Name: | (3S)-1-[(2S)-2-(3-chloro-6-fluoropyridin-2-yl)propanoyl]piperidine-3-carboxamide | Formula: | C14 H17 Cl F N3 O2 | SMILES: | O=C(C(C)c1nc(F)ccc1Cl)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C14H17ClFN3O2/c1-8(12-10(15)4-5-11(16)18-12)14(21)19-6-2-3-9(7-19)13(17)20/h4-5,8-9H,2-3,6-7H2,1H3,(H2,17,20)/t8-,9-/m0/s1 | Definition date: | 2025-03-24 | Last modified: | 2025-03-28 | Release date: | 2025-04-02 | Identifier: | (3S)-1-[(2S)-2-(3-chloro-6-fluoropyridin-2-yl)propanoyl]piperidine-3-carboxamide |
|
 | A1B5V | Name: | (4S)-1-{[5-bromo-2-(methylsulfanyl)phenyl]acetyl}azepane-4-carboxamide | Formula: | C16 H21 Br N2 O2 S | SMILES: | O=C(Cc1cc(Br)ccc1SC)N1CCCC(CC1)C(N)=O | InChi: | InChI=1S/C16H21BrN2O2S/c1-22-14-5-4-13(17)9-12(14)10-15(20)19-7-2-3-11(6-8-19)16(18)21/h4-5,9,11H,2-3,6-8,10H2,1H3,(H2,18,21)/t11-/m0/s1 | Definition date: | 2025-03-24 | Last modified: | 2025-03-28 | Release date: | 2025-04-02 | Identifier: | (4S)-1-{[5-bromo-2-(methylsulfanyl)phenyl]acetyl}azepane-4-carboxamide |
|
 | A1BWT | Name: | (3R)-4-({(2S)-1-[(5-acetamidopentyl)amino]-1-oxo-3-phenylpropan-2-yl}amino)-3-hydroxy-4-oxobutanoic acid | Formula: | C20 H29 N3 O6 | SMILES: | O=C(O)CC(O)C(=O)NC(Cc1ccccc1)C(=O)NCCCCCNC(C)=O | InChi: | InChI=1S/C20H29N3O6/c1-14(24)21-10-6-3-7-11-22-19(28)16(12-15-8-4-2-5-9-15)23-20(29)17(25)13-18(26)27/h2,4-5,8-9,16-17,25H,3,6-7,10-13H2,1H3,(H,21,24)(H,22,28)(H,23,29)(H,26,27)/t16-,17+/m0/s1 | Definition date: | 2025-02-14 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | (3R)-4-({(2S)-1-[(5-acetamidopentyl)amino]-1-oxo-3-phenylpropan-2-yl}amino)-3-hydroxy-4-oxobutanoic acid |
|
 | A1EBM | Name: | (~{Z})-5-methyl-2-propan-2-yl-hex-2-enal | Formula: | C10 H18 O | SMILES: | CC(C)CC=C(C=O)C(C)C | InChi: | InChI=1S/C10H18O/c1-8(2)5-6-10(7-11)9(3)4/h6-9H,5H2,1-4H3/b10-6+ | Definition date: | 2024-09-06 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | (~{Z})-5-methyl-2-propan-2-yl-hex-2-enal |
|
 | YTL | Name: | (2~{S})-2-(2-azanylethanoyloxy)-3-(4-hydroxyphenyl)propanoic acid | Formula: | C11 H13 N O5 | SMILES: | NCC(=O)O[CH](Cc1ccc(O)cc1)C(O)=O | InChi: | InChI=1S/C11H13NO5/c12-6-10(14)17-9(11(15)16)5-7-1-3-8(13)4-2-7/h1-4,9,13H,5-6,12H2,(H,15,16)/t9-/m0/s1 | Definition date: | 2023-02-21 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | (2~{S})-2-(2-azanylethanoyloxy)-3-(4-hydroxyphenyl)propanoic acid |
|
 | A1H7R | Name: | (2S)-1-(4-bromophenyl)propan-2-amine | Formula: | C9 H12 Br N | SMILES: | C[CH](N)Cc1ccc(Br)cc1 | InChi: | InChI=1S/C9H12BrN/c1-7(11)6-8-2-4-9(10)5-3-8/h2-5,7H,6,11H2,1H3 | Synonyms: | N,N'-(9-{[4-(dimethylamino)phenyl]amino}acridine-3,6-diyl)bis(3-pyrrolidin-1-ylpropanamide) | Definition date: | 2024-04-05 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | (2~{S})-1-(4-bromophenyl)propan-2-amine |
|
 | A1L8M | Name: | [(2S)-1-oxidanyl-3-[(E)-tetradec-9-enoyl]oxy-propan-2-yl] (Z)-pentadec-9-enoate | Formula: | C32 H58 O5 | SMILES: | CCCCCC=CCCCCCCCC(=O)O[CH](CO)COC(=O)CCCCCCCC=CCCCC | InChi: | InChI=1S/C32H58O5/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-32(35)37-30(28-33)29-36-31(34)26-24-22-20-18-16-14-12-10-8-6-4-2/h10-13,30,33H,3-9,14-29H2,1-2H3/b12-10+,13-11-/t30-/m0/s1 | Definition date: | 2025-03-07 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | [(2~{S})-1-oxidanyl-3-[(~{E})-tetradec-9-enoyl]oxy-propan-2-yl] (~{Z})-pentadec-9-enoate |
|
 | A1B0W | Name: | N-[3-(azepan-1-yl)propyl]-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]quinoline-2-carboxamide | Formula: | C22 H27 N3 O2 S | SMILES: | O=C(NCCCN1CCCCCC1)c1cc2C(=O)N(C)c3ccccc3c2s1 | InChi: | InChI=1S/C22H27N3O2S/c1-24-18-10-5-4-9-16(18)20-17(22(24)27)15-19(28-20)21(26)23-11-8-14-25-12-6-2-3-7-13-25/h4-5,9-10,15H,2-3,6-8,11-14H2,1H3,(H,23,26) | Definition date: | 2025-03-18 | Last modified: | 2025-03-21 | Release date: | 2025-03-26 | Identifier: | N-[3-(azepan-1-yl)propyl]-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]quinoline-2-carboxamide |
|
 | A1ITU | Name: | (4S)-4-[(1R)-2-[2-(3-methoxyphenyl)propan-2-ylamino]-1-oxidanyl-ethyl]-16-propyl-3,16-diazatricyclo[16.3.1.1^{6,10}]tricosa-1(21),6,8,10(23),18(22),19-hexaene-2,17-dione | Formula: | C36 H47 N3 O4 | SMILES: | CCCN1CCCCCc2cccc(C[CH](NC(=O)c3cccc(c3)C1=O)[CH](O)CNC(C)(C)c4cccc(OC)c4)c2 | InChi: | InChI=1S/C36H47N3O4/c1-5-19-39-20-8-6-7-12-26-13-9-14-27(21-26)22-32(38-34(41)28-15-10-16-29(23-28)35(39)42)33(40)25-37-36(2,3)30-17-11-18-31(24-30)43-4/h9-11,13-18,21,23-24,32-33,37,40H,5-8,12,19-20,22,25H2,1-4H3,(H,38,41)/t32-,33+/m0/s1 | Definition date: | 2024-11-12 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | (4~{S})-4-[(1~{R})-2-[2-(3-methoxyphenyl)propan-2-ylamino]-1-oxidanyl-ethyl]-16-propyl-3,16-diazatricyclo[16.3.1.1^{6,10}]tricosa-1(21),6,8,10(23),18(22),19-hexaene-2,17-dione |
|
 | A1AIE | Name: | N-{(4M)-4-[5-(aminomethyl)thiophen-2-yl]quinolin-8-yl}-4-[(propan-2-yl)oxy]benzamide | Formula: | C24 H23 N3 O2 S | SMILES: | NCc1ccc(s1)c1ccnc2c1cccc2NC(=O)c1ccc(OC(C)C)cc1 | InChi: | InChI=1S/C24H23N3O2S/c1-15(2)29-17-8-6-16(7-9-17)24(28)27-21-5-3-4-20-19(12-13-26-23(20)21)22-11-10-18(14-25)30-22/h3-13,15H,14,25H2,1-2H3,(H,27,28) | Definition date: | 2024-03-18 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | N-{(4M)-4-[5-(aminomethyl)thiophen-2-yl]quinolin-8-yl}-4-[(propan-2-yl)oxy]benzamide |
|
 | A1AIF | Name: | (5M)-5-{8-[({4-[(propan-2-yl)oxy]phenyl}methyl)amino]quinolin-4-yl}pyridine-2-carbonitrile | Formula: | C25 H22 N4 O | SMILES: | N#Cc1ccc(cn1)c1ccnc2c1cccc2NCc1ccc(OC(C)C)cc1 | InChi: | InChI=1S/C25H22N4O/c1-17(2)30-21-10-6-18(7-11-21)15-29-24-5-3-4-23-22(12-13-27-25(23)24)19-8-9-20(14-26)28-16-19/h3-13,16-17,29H,15H2,1-2H3 | Definition date: | 2024-03-18 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | (5M)-5-{8-[({4-[(propan-2-yl)oxy]phenyl}methyl)amino]quinolin-4-yl}pyridine-2-carbonitrile |
|
 | A1H8X | Name: | 4-fluoranyl-~{N}-[(2~{S})-1-[[4-[(2-methyl-1-oxidanyl-propan-2-yl)sulfamoyl]phenyl]amino]-1-oxidanylidene-3-phenyl-propan-2-yl]benzamide | Formula: | C26 H28 F N3 O5 S | SMILES: | CC(C)(CO)N[S](=O)(=O)c1ccc(NC(=O)[CH](Cc2ccccc2)NC(=O)c3ccc(F)cc3)cc1 | InChi: | InChI=1S/C26H28FN3O5S/c1-26(2,17-31)30-36(34,35)22-14-12-21(13-15-22)28-25(33)23(16-18-6-4-3-5-7-18)29-24(32)19-8-10-20(27)11-9-19/h3-15,23,30-31H,16-17H2,1-2H3,(H,28,33)(H,29,32) | Synonyms: | NK036 USP30 inhibitor | Definition date: | 2024-04-20 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | 4-fluoranyl-~{N}-[(2~{S})-1-[[4-[(2-methyl-1-oxidanyl-propan-2-yl)sulfamoyl]phenyl]amino]-1-oxidanylidene-3-phenyl-propan-2-yl]benzamide |
|
 | ULU | Name: | ~{N}-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]propyl]-3-[(azanylidene-$l^{4}-azanylidene)amino]propanamide | Formula: | C29 H38 N15 O8 | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CN(CCCNC(=O)CCN=[N]=N)CC#Cc4nc5c(N)ncnc5n4[CH]6O[CH](CO)[CH](O)[CH]6O)[CH](O)[CH]3O | InChi: | InChI=1S/C29H38N15O8/c30-24-18-26(36-11-34-24)43(13-38-18)28-22(49)20(47)14(51-28)9-42(8-2-5-33-17(46)4-6-39-41-32)7-1-3-16-40-19-25(31)35-12-37-27(19)44(16)29-23(50)21(48)15(10-45)52-29/h11-15,20-23,28-29,32,45,47-50H,2,4-10H2,(H,33,46)(H2,30,34,36)(H2,31,35,37)/t14-,15+,20+,21+,22+,23+,28-,29-/m0/s1 | Definition date: | 2023-09-06 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | ~{N}-[3-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl]amino]propyl]-3-[(azanylidene-$l^{4}-azanylidene)amino]propanamide |
|
 | UWF | Name: | (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-[[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl-propan-2-yl-amino]methyl]oxolane-3,4-diol | Formula: | C26 H33 N11 O7 | SMILES: | CC(C)N(CC#Cc1nc2c(N)ncnc2n1[CH]3O[CH](CO)[CH](O)[CH]3O)C[CH]4O[CH]([CH](O)[CH]4O)n5cnc6c(N)ncnc56 | InChi: | InChI=1S/C26H33N11O7/c1-11(2)35(6-12-17(39)19(41)25(43-12)36-10-33-15-21(27)29-8-31-23(15)36)5-3-4-14-34-16-22(28)30-9-32-24(16)37(14)26-20(42)18(40)13(7-38)44-26/h8-13,17-20,25-26,38-42H,5-7H2,1-2H3,(H2,27,29,31)(H2,28,30,32)/t12-,13-,17-,18-,19-,20-,25-,26-/m1/s1 | Definition date: | 2023-09-07 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-[[3-[6-azanyl-9-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]prop-2-ynyl-propan-2-yl-amino]methyl]oxolane-3,4-diol |
|
 | CCJ | Name: | Carboxymthylated D- Cysteine | Formula: | C5 H9 N O4 S | SMILES: | N[CH](CSCC(O)=O)C(O)=O | InChi: | InChI=1S/C5H9NO4S/c6-3(5(9)10)1-11-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m1/s1 | Definition date: | 2017-06-01 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | (2~{S})-2-azanyl-3-(2-hydroxy-2-oxoethylsulfanyl)propanoic acid |
|
 | WK6 | Name: | L-gamma-glutamyl-S-(benzylcarbamothioyl)-L-cysteinylglycine | Formula: | C18 H24 N4 O6 S2 | SMILES: | O=C(O)C(N)CCC(=O)NC(CSC(=S)NCc1ccccc1)C(=O)NCC(=O)O | InChi: | InChI=1S/C18H24N4O6S2/c19-12(17(27)28)6-7-14(23)22-13(16(26)20-9-15(24)25)10-30-18(29)21-8-11-4-2-1-3-5-11/h1-5,12-13H,6-10,19H2,(H,20,26)(H,21,29)(H,22,23)(H,24,25)(H,27,28)/t12-,13+/m0/s1 | Definition date: | 2023-10-05 | Last modified: | 2025-03-14 | Release date: | 2025-03-19 | Identifier: | L-gamma-glutamyl-S-(benzylcarbamothioyl)-L-cysteinylglycine |
|
 | B1M | Name: | CO-5-METHOXYBENZIMIDAZOLYLCOBAMIDE | Formula: | C61 H86 Co N13 O15 P | SMILES: | NC(=O)CCC1C2=[N+]3C(=CC4=[N+]5C(=C(C)C6=[N+]7[Co]35[N+]=3C(=C2C)C(C)(CCC(=O)NCC(C)OP(=O)(O)OC2C(CO)OC(n5cnc8cc(OC)ccc85)C2O)C(CC(N)=O)C=3C7(C)C(C)(CC(N)=O)C6CCC(N)=O)C(C)(CC(N)=O)C4CCC(N)=O)C1(C)C | InChi: | InChI=1S/C61H86N13O15P.Co/c1-29(88-90(84,85)89-52-40(27-75)87-56(51(52)83)74-28-69-38-21-32(86-10)11-15-39(38)74)26-68-48(82)19-20-58(6)36(22-45(65)79)55-61(9)60(8,25-47(67)81)35(14-18-44(64)78)50(73-61)31(3)54-59(7,24-46(66)80)33(12-16-42(62)76)37(70-54)23-41-57(4,5)34(13-17-43(63)77)49(71-41)30(2)53(58)72-55 | Synonyms: | FACTOR IIIM | Definition date: | 2005-01-07 | Last modified: | 2025-03-12 | Identifier: | [(2R,3S,4R,5S)-4-hydroxy-2-(hydroxymethyl)-5-(5-methoxy-1H-1,3-benzimidazol-1-yl)oxolan-3-yl (2R)-1-{3-[(1R,3R,4R,8S,13S,14S,18S,19S)-3,14,19-tris(2-amino-2-oxoethyl)-8,13,18-tris(3-amino-3-oxopropyl)-1,4,6,9,9,14,16,19-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1~2,5~.1~7,10~.1~12,15~]tricosa-2(23),5,7(22),10,12(21),15,17(20)-heptaen-4-yl-kappa~4~N~20~,N~21~,N~22~,N~23~]propanamido}propan-2-yl hydrogen (S)-phosphato]cobalt(4+) (non-preferred name) |
|
 | A1D6U | Name: | ~{N},~{N}-dimethyl-7-propan-2-yl-3-thia-5-aza-1,6-diazonia-2$l^{3}-cupratricyclo[6.4.0.0^{2,6}]dodeca-1(12),4,6,8,10-pentaen-4-amine | Formula: | C12 H17 Cu N4 S | SMILES: | CC(C)C1=[N+]2N=C(S[Cu]2[n+]3ccccc13)N(C)C | InChi: | InChI=1S/C12H18N4S.Cu/c1-9(2)11(10-7-5-6-8-13-10)14-15-12(17)16(3)4 | Definition date: | 2024-03-15 | Last modified: | 2025-03-07 | Release date: | 2025-03-12 | Identifier: | ~{N},~{N}-dimethyl-7-propan-2-yl-3-thia-5-aza-1,6-diazonia-2$l^{3}-cupratricyclo[6.4.0.0^{2,6}]dodeca-1(12),4,6,8,10-pentaen-4-amine |
|
 | A1D9R | Name: | (2~{S})-2-[[6-methoxy-2-[(2-methyl-3-phenyl-phenyl)amino]pyrimidin-4-yl]methylamino]-3-oxidanyl-propanoic acid | Formula: | C22 H24 N4 O4 | SMILES: | COc1cc(CN[CH](CO)C(O)=O)nc(Nc2cccc(c2C)c3ccccc3)n1 | InChi: | InChI=1S/C22H24N4O4/c1-14-17(15-7-4-3-5-8-15)9-6-10-18(14)25-22-24-16(11-20(26-22)30-2)12-23-19(13-27)21(28)29/h3-11,19,23,27H,12-13H2,1-2H3,(H,28,29)(H,24,25,26)/t19-/m0/s1 | Definition date: | 2024-07-09 | Last modified: | 2025-03-07 | Release date: | 2025-03-12 | Identifier: | (2~{S})-2-[[6-methoxy-2-[(2-methyl-3-phenyl-phenyl)amino]pyrimidin-4-yl]methylamino]-3-oxidanyl-propanoic acid |
|
 | A1L2F | Name: | [(2~{R})-1-octadecanoyloxy-3-[oxidanyl-[(2~{R},3~{S},5~{R},6~{R})-2,3,5,6-tetrakis(oxidanyl)-4-phosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propan-2-yl] nonadecanoate | Formula: | C46 H90 O16 P2 | SMILES: | CCCCCCCCCCCCCCCCCCC(=O)O[CH](COC(=O)CCCCCCCCCCCCCCCCC)CO[P](O)(=O)O[CH]1[CH](O)[CH](O)[CH](O[P](O)(O)=O)[CH](O)[CH]1O | InChi: | InChI=1S/C46H90O16P2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-40(48)60-38(36-58-39(47)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)37-59-64(56,57)62-46-43(51)41(49)45(42(50)44(46)52)61-63(53,54)55/h38,41-46,49-52H,3-37H2,1-2H3,(H,56,57)(H2,53,54,55)/t38-,41-,42+,43-,44-,45-,46+/m1/s1 | Definition date: | 2024-06-13 | Last modified: | 2025-03-07 | Release date: | 2025-03-12 | Identifier: | [(2~{R})-1-octadecanoyloxy-3-[oxidanyl-[(2~{R},3~{S},5~{R},6~{R})-2,3,5,6-tetrakis(oxidanyl)-4-phosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propan-2-yl] nonadecanoate |
|
 | A1L6B | Name: | 7-[2-azanyl-3,4,5,6-tetrakis(fluoranyl)phenyl]-6-chloranyl-1-(4-methyl-2-propan-2-yl-pyridin-3-yl)-2-oxidanylidene-4-(4-prop-2-enoylpiperazin-1-yl)-1,8-naphthyridine-3-carbonitrile | Formula: | C31 H26 Cl F4 N7 O2 | SMILES: | CC(C)c1nccc(C)c1N2C(=O)C(=C(N3CCN(CC3)C(=O)C=C)c4cc(Cl)c(nc24)c5c(N)c(F)c(F)c(F)c5F)C#N | InChi: | InChI=1S/C31H26ClF4N7O2/c1-5-19(44)41-8-10-42(11-9-41)29-16-12-18(32)27(20-21(33)22(34)23(35)24(36)25(20)38)40-30(16)43(31(45)17(29)13-37)28-15(4)6-7-39-26(28)14(2)3/h5-7,12,14H,1,8-11,38H2,2-4H3 | Definition date: | 2024-11-25 | Last modified: | 2025-03-07 | Release date: | 2025-03-12 | Identifier: | 7-[2-azanyl-3,4,5,6-tetrakis(fluoranyl)phenyl]-6-chloranyl-1-(4-methyl-2-propan-2-yl-pyridin-3-yl)-2-oxidanylidene-4-(4-prop-2-enoylpiperazin-1-yl)-1,8-naphthyridine-3-carbonitrile |
|